Therapeutics interventions with anti-inflammatory creams in post radiation acute skin reactions: A systematic review of most important clinical trials

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 4, Issue 2, 2010, Pages 149-158

  Koukourakis, Georgios V ^a,b   Kelekis, Nikolaos ^b   Kouvaris, John ^c   Beli, Ivelina K ^b   Kouloulias, Vassilios E ^b  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute skin reactions; Dermatitis; Management; Post radiation complications

Indexed keywords

ALOE VERA EXTRACT; BIAFINE; CLOBETASONE BUTYRATE; CORTICOSTEROID; DERMATOLOGICAL AGENT; DERMOFILM; EMOLLIENT AGENT; HERBACEOUS AGENT; HYALURONIC ACID; HYDROCORTISONE; LIPIDERM; MOMETASONE FUROATE; SORBOLENE; SUCRALFATE; SULFADIAZINE SILVER; TROLAMINE; UNCLASSIFIED DRUG;

ACUTE RADIATION SYNDROME; ALOE VERA; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BANDAGES AND DRESSINGS; BURN; CLINICAL TRIAL; CREAM; DESQUAMATION; DRUG CONTRAINDICATION; DRUG FORMULATION; DRY SKIN; HUMAN; HYDROCOLLOID DRESSING; HYDROPHILIC DRESSING; LOTION; MARIGOLD; OINTMENT; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIOTHERAPY; REVIEW; SILVER DRESSING; SKIN BURNING SENSATION; SKIN MANIFESTATION; SKIN PIGMENTATION; SKIN TOXICITY; SYSTEMATIC REVIEW; TREATMENT DURATION; WOUND HEALING;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; DERMATOLOGIC AGENTS; GLUCOCORTICOIDS; HUMANS; NEOPLASMS; PATENTS AS TOPIC; RADIODERMATITIS; SEVERITY OF ILLNESS INDEX;

EID: 77954048831     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221310791163099     Document Type: Review

References (71)

1. Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: The use and impact of topical agents and dressings. Eur J Cancer Care 1999; 8: 143-53.
2. Campbell J, Lane C. Developing a skin-care protocol in radiotherapy. Prof Nurse 1996; 12(2): 105-8.
3. th ed. Jones and Bartlett Publishers: Boston 1997.
4. Blackmar A. Focus on wound care: Radiation induced skin alterations. Medsurg Nurs 1997; 6(3): 172-5.
5. Korinko A, Yurick A. Maintaining skin integrity during radiotherapy. Am J Nurs 1997; 97: 40-4.
6. Bolderston A. Skin care recommendations during radiotherapy: A survey of Canadian practice. Can J Med Radiat Technol 2002; 34: 3-11.
7. Oka, S., Tsuruda, A. UV-induced dermatitis inhibitor and atopic dermatitis inhibitor. US20090215702 (2009).
8. Bolderston A, Lloyd NS, Wong RK, Holden L, Robb-Blenderman L. The prevention and management of acute skin reactions related to radiation therapy: A systematic review and practice guideline. Support Care Cancer 2006; 14(8): 802-17.
9. Hill A, Hanson M, Bogle MA, Duvic M. Severe radiation dermatitis is related to Staphylococcus aureus. Am J Clin Oncol 2004; 27(4): 361-3.
10. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
11. Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC trial. J Clin Oncol 2006; 24: 2873-8.
12. Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA, Eastern Cooperative Oncology Group. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 2005; 23: 8646-54.
13. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-6.
14. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998; 16: 1318-24.
15. Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 prospective randomized trial. J Clin Oncol 2005; 23: 1125-35.
16. Chao KS, Ozyigit G, Thorsdad WL. Toxicity profile of intensitymodulated radiation therapy for head and neck carcinoma and potential role of amifostine. Semin Oncol 2003; 30: 101-8.
17. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamouscell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-78.
18. Hymes SR, Strom EA, Fife C. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54: 28-46.
19. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-8.
20. Elliott EA, Wright JR, Swann RS, Nguyen-Tan F, Takita C, Bucci MK, et al. Phase III trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: Results of Radiation Taxane Oncology Group Trial 99-13. J Clin Oncol 2006; 24: 2092-7.
21. Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001; 61: 223-31.
22. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 2004; 22: 19-22.
23. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf
24. Candau, D., Duranton, A., Pruche, F., Richard, H. Aminoarylvinyls- triazine compounds and uses thereof. US2009074820 (2009).
25. Bolderston A. Skin care recommendations during radiotherapy: A survey of Canadian practice. Can J MRT 2003; 34: 3-11.
26. Bolderston A, Lloyd NS, Wong RKS, Holden L, Robb-Blenderman L, Members of the Supportive Care Guidelines Group. Program in evidence-based care. A Cancer Care Ontario program. Available at www.cancercare.on.ca (accessed on: May 11, 2006).
27. Nystedt KE, Hill JE, Mitchell AM, Goodwin F, Rowe LA, Wong FL, et al. The standardization of radiation skin care in British Columbia: A collaborative approach. Oncol Nurs Forum 2005; 32: 1199-205.
28. Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol 1992; 4: 78-82.
29. Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: A randomized study. Radiother Oncol 2001; 58: 333-9.
30. Frosch P, Kligman A. The soap chamber: A new method for assessing the irritancy of soaps. J Am Acad Dermatol 1979; 1: 35-41.
31. Westbury C, Hines F, Hawkes E, Ashley S, Brada M. Advice on hair and scalp care during cranial radiotherapy: A prospective randomized trial. Radiother Oncol 2000; 54: 109 16.
32. Burch SE, Parker SA, Vann AM, Arazie JC. Measurement of 6- MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys 1997; 38: 447-51.
33. Xiaojuan, L., Yongguang, L., Hongying, L., Xia, G., Yanpeng, W. Proprietary Chinese medicine medical ointment for treating radiation dermatitis. CN101401866 (2009).
34. Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J, et al. A phase II study on the efficacy of topical Aloe vera gel on irradiated breast tissue. Cancer Nurs 2002; 25: 442-51.
35. Olsen DL, Raub W, Bradley C, Johnson M, Macias JL, Love V, et al. The effect of Aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum 2001; 3: 543-7.
36. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, et al. Phase III double-blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36: 345-9.
37. Dudek DJ, Thompson J, Meegan MM, Haycocks TR, Barbieri C, Manchul LA. Pilot study to investigate the toxicity of Aloe vera gel in the management of radiation induced skin reactions for postoperative primary breast cancer. J Radiother Pract 2000; 1: 197-204.
38. Vogler BK, Ernst E. Aloe vera: A systematic review of its clinical effectiveness. Br J General Pract 1999; 49: 823-8.
39. Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, et al. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000; 48: 1307-10.
40. Fenig E, Brfenner B, Katz A, Sulkes J, Lapidot M, Schachter J, et al. Topical Biafine and Liperderm for the prevention of radiation dermatitis: A randomized prospective trial. Oncol Rep 2001; 8: 305-9.
41. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X, et al. Phase III randomized trial of Calendual Officinalis compared with Tromaline for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004; 22: 1447-53.
42. Foschi D, Castoldi L, Radaelli E, Abelli P, Calderini G, Rastrelli A, et al. Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: A study in rats. Int J Tissue React 1990; 12: 333-39.
43. Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Berneir J. Double-blind randomized clinical trial comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997; 42: 155-61.
44. Primavera G, Carrera M, Berardesca E, Pinnaró P, Messina M, Arcangeli G. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acidbased formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol 2006; 25(3): 165-71.
45. Leonardi MC, Gariboldi S, Ivaldi GB, Ferrari A, Serafini F, Didier F, et al. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: Interim analysis. Eur J Dermatol 2008; 18(3): 317-21.
46. Yohn JJ, Weston WL. Topical corticosteroids, in Weston WL (ed): Current Problems in Dermatology. Chicago, IL, Year Book Medical 1990; 11: 34-64.
47. Bostrom A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double-blind randomized study. Radiother Oncol 2001; 59: 257-65.
48. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, et al. Topical corticosteroid therapy for acute radiation dermatitis: A prospective randomized, double-blind study. Br J Dermatol 2002; 146: 983-91.
49. Glees JP, Mamaghan-Zadeh H, Sparkes CG. Effectiveness of topical steroids in the control of radiation dermatitis: A randomized trial using 1% hydrocortisone cream and 0.05% Clobestasone Butyrate (Eumovate). Clin Radiol 1979; 30: 397-403.
50. Potera ME, Lookingbill DP, Stryker JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology 1982; 143: 775-7.
51. Konturek S, Brozozowski P, Bielanski W. Epidermal growth factor in the gastroprotective and ulcer healing action of sucralfate in rats. Am J Med 1989; 86: 32-7.
52. Romano M, Razandi M, Ivey K. Effect of sucralfate and its components on taurocholate-induced damage to rate gastric mucosal cells in tissue culture. Dig Dis Sci 1990; 35: 467-74.
53. Evensen JF, Bjordal K, Jacobsen A-B, Lokkevik E, Tausjo JE. Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers. Acta Oncol 2001; 40: 751-55.
54. Maiche A, Isokangas OP, Grohn P. Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 1994; 33: 201-203.
55. Wells M, Macmillan M, Raab G, MacBride S, Bell N, MacKinnon K, et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol 2004; 73: 153-62.
56. Kneebone A, Mameghan H, Bolin T, Berry M, Turner S, Kearsley J, et al. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind randomized trial. Int J Radiat Oncol Biol Phys 2004; 60: 1088-97.
57. Lievens Y, Haustermans K, Van den Weyngaert D, Van den Bogaert W, Scalliet P, Hutsebaut L, et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol 1998; 47: 149-53.
58. Delaney G, Fisher R, Hook C, Barton M. Sucralfate cream in the management of moist desquamation during radiotherapy. Australas Radiol 1997; 41: 270-5.
59. Graham P, Browne L, Capp A, Fox C, Graham J, Hollis J, et al. Randomized paired comparison of No-Sting barrier film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation. Int J Radiat Oncol Biol Phys 2004; 58: 241-246.
60. See A, Wright S, Denham JW. A pilot study of Dermofilm in acute radiation-induced desquamative skin reactions. Clin Oncol 1998; 10: 182-5.
61. Spann TC, Tutrone WD, Weinberg JM, Scheinfeld N, Ross B. Topical antibacterial agents for wound care: A primer. Dermatol Surg 2003; 29: 620-6.
62. Korinko A, Yurick A. Maintaining skin integrity during radiation therapy. Am J Nurs 1997; 97: 40-4.
63. Hom D, Adams G, Koreis M, Maisel R. Choosing the optimal wound dressing for irradiated soft tissue wounds. Otolaryngol Head Neck Surg 1999; 121: 591-8.
64. Winter G. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-4.
65. Shell JA, Stanutz F, Grimm J. Comparison of moisture vapor permeable (MVP) dressings to conventional dressings for the management of radiation skin reactions. Oncol Nurs Forum 1986; 13: 11-6.
66. Margolin SG, Brfeneman JC, Denman DL, LaChapelle P, Weckbach L, Aron BS. Management of radiation-induced moist skin desquamation using hydrocolloid dressing. Cancer Nurs 1990; 13: 71-80.
67. Mak S, Molassiotis A, Wan W, Lee IY, Chan ES. The effects of hydrocolloid dressing and gentian violet on radiation induced moist desquamation wound healing. Cancer Nurs 2000; 23: 220-9.
68. Dowsett C. An overview of Acticoat dressing in wound management. Br J Nurs 2003; 12: S44-S49.
69. Lansdown ABG. A guide to the properties and uses of silver dressings in wound care. Prof Nurs 2005; 20: 41-3.
70. Vuong T, Franco E, Lehnert S, Lambert C, Portelance L, Nasr E, et al. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys 2004; 59: 809-14.
71. Muroyama, K., Ohara, T., Hirose, Y., Yamamoto, N., Murosaki, S., Yamamoto, Y. Moisturizer. US20090281198 (2009).